What is LOPJLB’s current signal on ABCL?

LOPJLB’s latest quantitative signal on AbCellera Biologics Inc. (ABCL) is BUY in a CRISIS regime. Signals are updated daily.

What market regime is ABCL in?

AbCellera Biologics Inc. (ABCL) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does AbCellera Biologics Inc. (ABCL) do?

AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or un…

Where is AbCellera Biologics Inc. based / listed?

AbCellera Biologics Inc. is based in CA, listed on NASDAQ.

AbCellera Biologics Inc. (ABCL)

COMPARE

Healthcare · Biotechnology · NASDAQ · CA

$12.55+4.41%Close

BUYCRISIS · day 2

[SCORES & PROFILE]

FUND: 1
VALUE: 1
GROWTH: 17
GARP: 5
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-10.5%

REV YoY-

ROE-17.5%

EPS YoY-

ROA-12.6%

GROSS

-340

NET

-249

[VALUATION]

P/E TTM-24.35

P/E FWD-

SECTOR PE20.47

INDUSTRY PE13.95

P/B4.48

P/FCF-

EV/EBITDA-25.15

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E15.14

ALTMAN Z-

CURR RATIO12.77

ND/EBITDA-

BETA1.19

AbCellera Biologics Inc. (ABCL)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news